Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Pliant Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get PLRX alerts

About Éric Lefebvre

Pliant Therapeutics, Inc. reported in an 8-K filed December 8, 2025 that Éric Lefebvre was terminated as Chief Medical Officer, effective December 15, 2025. The proxy statement of Pliant Therapeutics, Inc. reports total compensation of $2,724,860 for Éric Lefebvre in fiscal 2025, including a base salary of $571,861. Disclosed compensation is on record for 6 fiscal years. Pliant Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Pliant Therapeutics, Inc. includes Bernard Coulie (CEO and Board Member), Keith Cummings (CFO), Minnie Kuo (COO) and 6 others.

“On December 2, 2025, Pliant Therapeutics, Inc. (the "Company") notified Éric Lefebvre, M.D., Chief Medical Officer, that Dr. Lefebvre's employment with the Company will terminate effective December 15, 2025 (the "Separation Date").”
Pliant Therapeutics, Inc. Form 8-K, filed December 8, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Pliant Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Pliant Therapeutics, Inc. (PLRX) $571,861 $2,724,860
2024 Pliant Therapeutics, Inc. (PLRX) $520,312 $2,615,618
2023 Pliant Therapeutics, Inc. (PLRX) $500,300 $4,687,061
2022 Pliant Therapeutics, Inc. (PLRX) $481,100 $3,903,337
2021 Pliant Therapeutics, Inc. (PLRX) $455,981 $1,974,231
2020 Pliant Therapeutics, Inc. (PLRX) $425,462 $874,671

Recent activity